the family office of Danish pharmaceutical group Orifarm
Investor profile
Venture capital
the family office of Danish pharmaceutical group Orifarm has backed 1 European tech company across 1 funding round in 2026, joining rounds totalling €4.3M. Most active in Healthtech. Data as of Nov 2026.
Deals
1
distinct rounds
Companies
1
backed
Active span
2026
1 yr
Total round €
€4.3M
sum of rounds joined
Deals by year
distinct rounds / yearthe family office of Danish pharmaceutical group Orifarm — deals by year — interactive chart.
Data table
| the family office of Danish pharmaceutical group Orifarm — deals by year | |
|---|---|
| 2026 | 1 |
Top sectors
by dealsthe family office of Danish pharmaceutical group Orifarm — top sectors — interactive chart.
Data table
| the family office of Danish pharmaceutical group Orifarm — top sectors | |
|---|---|
| Healthtech | 1 |
Stages
by dealsthe family office of Danish pharmaceutical group Orifarm — stages — interactive chart.
Data table
| the family office of Danish pharmaceutical group Orifarm — stages | |
|---|---|
| Seed | 1 |
Countries
by dealsthe family office of Danish pharmaceutical group Orifarm — countries — interactive chart.
Data table
| the family office of Danish pharmaceutical group Orifarm — countries | |
|---|---|
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Allos | UK | 1 | €4.3M |